Table 1 Table of individual patients showing the mutation location, cDNA and protein consequences, and variant allele frequencies (VAF)
From: Somatic activating mutations in MAP2K1 cause melorheostosis
Subject | AA Changes | VAF WES affected bone | VAF WES unaffected bone | VAF amplicon affected bone | VAF ddPCR affected bone | VAF ddPCR unaffected bone | VAF ddPCR skin | VAF ddPCR unaffected skin | VAF ddPCR blood |
---|---|---|---|---|---|---|---|---|---|
melo4 | NM_002755:exon2:c.A167C:p.Q56P | 10.1%a | 0.00% | N.D. | 9.4% | 0.0% | 12.5% | 0.0% | 0.0% |
melo9 | NM_002755:exon2:c.A167C:p.Q56P | 17.19%a | 0.00% | N.D. | 20.0% | 0.0% | N.D. | N.D. | 0.0% |
melo19 | NM_002755:exon2:c.A167C:p.Q56P | 30.86%a | 0.99% | 27.9% | 27.8% | 0.0% | N.D. | N.D. | N.D. |
melo10 | NM_002755:exon2:c.A169G:p.K57E | 12.07%a | 0.00% | 16.7% | 18.3% | 0.0% | N.D. | N.D. | 0.0% |
melo2 | NM_002755:exon2:c.G171T:p.K57N | 6.09% | 0.00% | 7.2% | 7.0% | 0.0% | 4.1% | 0.0% | 0.0% |
melo6 | NM_002755:exon2:c.G171T:p.K57N | 3.12% | 0.00% | 4.8% | 4.4% | 0.0% | 16.2% | 0.0% | 0.0% |
melo16 | NM_002755:exon2:c.G171T:p.K57N | 1.04% | 0.00% | 2.7% | 2.8% | 0.0% | 0.0% | 0.0% | 0.0% |
melo18 | NM_002755:exon2:c.G171T:p.K57N | 25.21%a | 0.0% | 34.4% | 33.6% | 0.0% | 6.5% | N.D. | 0.0% |